Clinical Trial Update: The Impact on Survival of Neo-adjuvant Transarterial Chemoinfusion (TAI) for Patients With Hepatocellular Carcinoma And Portal Vein Tumor Thrombosis (PVTT) Who Underwent Hepatectomy : A Random, Controlled, Stage III Clinical Trial. [Phase 3]

View source ↗

Summary

A Phase 3 randomized trial evaluating whether neo-adjuvant transarterial chemoinfusion improves survival for patients with hepatocellular carcinoma and portal v…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Snippet

Sponsor: Sun Yat-sen University | Conditions: Hepatocellular Carcinoma | Phase 3 | Status: RECRUITING